Literature DB >> 24119210

Nutrition and nutraceutical supplements for the treatment of hypertension: part III.

Mark Houston1.   

Abstract

Vascular biology, endothelial and vascular smooth muscle, and cardiac dysfunction play a primary role in the initiation and perpetuation of hypertension, cardiovascular disease, and target organ damage. Nutrient-gene interactions and epigenetics are predominant factors in promoting beneficial or detrimental effects in cardiovascular health and hypertension. Macronutrients and micronutrients can prevent, control, and treat hypertension through numerous mechanisms related to vascular biology. Oxidative stress, inflammation, and autoimmune dysfunction initiate and propagate hypertension and cardiovascular disease. There is a role for the selected use of single and component nutraceutical supplements, vitamins, antioxidants, and minerals in the treatment of hypertension based on scientifically controlled studies that complement optimal nutrition, coupled with other lifestyle modifications. ©2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24119210      PMCID: PMC8033946          DOI: 10.1111/jch.12211

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  76 in total

1.  Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome.

Authors:  Brahmesh Sivaprakasapillai; Indika Edirisinghe; Jody Randolph; Francene Steinberg; Tissa Kappagoda
Journal:  Metabolism       Date:  2009-07-15       Impact factor: 8.694

Review 2.  Drug-nutrient interactions.

Authors:  A Trovato; D N Nuhlicek; J E Midtling
Journal:  Am Fam Physician       Date:  1991-11       Impact factor: 3.292

3.  Sympathetic stimulation and hypertension in the pyridoxine-deficient adult rat.

Authors:  C S Paulose; K Dakshinamurti; S Packer; N L Stephens
Journal:  Hypertension       Date:  1988-04       Impact factor: 10.190

4.  Low vs. higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients.

Authors:  Steffen Desch; Daniela Kobler; Johanna Schmidt; Melanie Sonnabend; Volker Adams; Mahdi Sareban; Ingo Eitel; Matthias Blüher; Gerhard Schuler; Holger Thiele
Journal:  Am J Hypertens       Date:  2010-03-04       Impact factor: 2.689

5.  Modulation of blood pressure, lipid profiles and redox status in hypertensive patients taking different edible oils.

Authors:  D Sankar; G Sambandam; M Ramakrishna Rao; K V Pugalendi
Journal:  Clin Chim Acta       Date:  2005-05       Impact factor: 3.786

6.  A pilot study of open label sesame oil in hypertensive diabetics.

Authors:  D Sankar; M Ramakrishna Rao; G Sambandam; K V Pugalendi
Journal:  J Med Food       Date:  2006       Impact factor: 2.786

7.  Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients.

Authors:  Ximing Liu; Junping Wei; Fengsen Tan; Shengming Zhou; Gudrun Würthwein; Peter Rohdewald
Journal:  Life Sci       Date:  2004-01-02       Impact factor: 5.037

Review 8.  Is there a place for coenzyme Q in the management of metabolic disorders associated with obesity?

Authors:  Florence M Sohet; Nathalie M Delzenne
Journal:  Nutr Rev       Date:  2012-09-25       Impact factor: 7.110

Review 9.  A systematic review on the influence of trial quality on the effect of garlic on blood pressure.

Authors:  S Simons; H Wollersheim; T Thien
Journal:  Neth J Med       Date:  2009-06       Impact factor: 1.422

10.  Acute, quercetin-induced reductions in blood pressure in hypertensive individuals are not secondary to lower plasma angiotensin-converting enzyme activity or endothelin-1: nitric oxide.

Authors:  Abigail Larson; Melissa A H Witman; Yi Guo; Stephen Ives; Russell S Richardson; Richard S Bruno; Thunder Jalili; J David Symons
Journal:  Nutr Res       Date:  2012-08-16       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.